Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

PubMed  Google Scholar 

Jokhadze N, Das A, Dizon DS. Global cancer statistics: a healthy population relies on population health. CA Cancer J Clin. 2024;74:224–6.

PubMed  Google Scholar 

Gilles H, Garbutt T, Landrum J. Hepatocellular carcinoma. Crit Care Nurs Clin. 2022;34:289–301.

Google Scholar 

Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. BBA Rev Cancer. 2020;1873:188314.

CAS  Google Scholar 

Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metast Rev. 2023;42:629–52.

Article  Google Scholar 

Lawo S, Bashkurov M, Mullin M, Ferreria MG, Kittler R, Habermann B, et al. HAUS, the 8-subunit human Augmin complex, regulates centrosome and spindle integrity. Curr Biol. 2009;19:816–26.

Article  CAS  PubMed  Google Scholar 

Uehara R, Nozawa RS, Tomioka A, Petry S, Vale RD, Obuse C, et al. The augmin complex plays a critical role in spindle microtubule generation for mitotic progression and cytokinesis in human cells. Proc Natl Acad Sci USA. 2009;106:6998–7003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho CM, Hotta T, Kong Z, Zeng CJ, Sun J, Lee YR, et al. Augmin plays a critical role in organizing the spindle and phragmoplast microtubule arrays in Arabidopsis. Plant Cell. 2011;23:2606–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao Q, Ge X, Lu Z, Shi J, Shen J, Chen J. HAUS Augmin-like complex subunit 1 Influences tumour microenvironment and prognostic outcomes in glioma. J Oncol. 2022;2022:8027686.

Article  PubMed  PubMed Central  Google Scholar 

Tang L, Chen Z, Wei C, Liu H, Wang B, Yu T, et al. The significance of HAUS1 and its relationship with immune microenvironment in hepatocellular carcinoma. J Cancer. 2024;15:1328–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Yang X, Xiong Y, Li R, Ito T, Ahmed TA, et al. Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders. Nat Cancer. 2021;2:429–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang Q, Mai C, Yang H, Wu Q, Hua S, Yan C, et al. Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma. Histopathology. 2014;64:722–30.

Article  PubMed  Google Scholar 

Du Q, Guo X, Wang M, Li Y, Sun X, Li Q. The application and prospect of CDK4/6 inhibitors in malignant solid tumors. J Hematol Oncol. 2020;13:41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fassl A, Geng Y, Sicinski P. CDK4 and CDK6 kinases: from basic science to cancer therapy. Science. 2022;375:eabc1495.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bai X, Guo ZQ, Zhang YP, Fan ZZ, Liu LJ, Liu L, et al. CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. Nat Commun. 2023;14:1247.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Luo J, Chen X, Yang Z, Mei X, Ma J, et al. CDK4/6 inhibitors: a novel strategy for tumor radiosensitization. J Exp Clin Canc Res. 2020;39:188.

Article  CAS  Google Scholar 

Hamilton E, Infante JR. Targeting CDK4/6 in patients with cancer. Cancer Treat Rev. 2016;45:129–38.

Article  CAS  PubMed  Google Scholar 

Sorokin AV, Kanikarla MP, Bitner L, Syed M, Woods M, Manyam G, et al. Targeting RAS mutant colorectal cancer with dual inhibition of MEK and CDK4/6. Cancer Res. 2022;82:3335–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen M, Chen W, Sun S, Lu Y, Wu G, Xu H, et al. CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells. J Adv Res. 2025;73:357–73.

Article  CAS  PubMed  Google Scholar 

Li P, Guo H, Wu K, Su L, Huang K, Lai R, et al. Decreased IL-37 expression in hepatocellular carcinoma tissues and liver cancer cell lines. Oncol Lett. 2020;19:2639–48.

CAS  PubMed  PubMed Central  Google Scholar 

Wei C, Wang B, Chen ZH, Xiao H, Tang L, Guan JF, et al. Validating RRP12 expression and its prognostic significance in HCC based on data mining and bioinformatics methods. Front Oncol. 2022;12:812009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun S, Li Q, Liu G, Huang X, Li A, Guo H, et al. Endosomal protein DENND10/FAM45A integrates extracellular vesicle release with cancer cell migration. BMC Biol. 2024;22:154.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu H, Yan Y, Yuan J, Luo M, Wang Y. miR-4324 inhibits ovarian cancer progression by targeting FEN1. J Ovarian Res. 2022;15:32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong H, Xiao H, Luo C, Chen L, Liu X, Hu Z, et al. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6. Exp Cell Res. 2019;383:111493.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Li H, Chang H, Du L, Hai J, Geng X, et al. MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma. Cell Death Dis. 2018;9:956.

Article  PubMed  PubMed Central  Google Scholar 

Liang J, Yang Y, Bai L, Li F, Li E. DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. J Gastroen Hepatol. 2020;35:885–95.

Article  CAS  Google Scholar 

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastro Hepat. 2019;16:589–604.

Article  Google Scholar 

Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Lett. 2018;412:283–8.

Article  CAS  PubMed  Google Scholar 

Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, et al. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroentero. 2023;29:1243–60.

Article  CAS  Google Scholar 

Gong CF, Sun YK, Xie YB. Advances in molecular classification and precision immunotherapy for gastric cancer. Zhonghua Yi Xue Za Zhi. 2021;101:2649–52.

CAS  PubMed